Vancomycin-resistant enterococci: A rising challenge to global health
Clinical Epidemiology and Global Health, ISSN: 2213-3984, Vol: 28, Page: 101663
2024
- 4Citations
- 6Usage
- 23Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations4
- Citation Indexes4
- CrossRef2
- Usage6
- Abstract Views6
- Captures23
- Readers23
- 23
- Mentions1
- News Mentions1
- News1
Review Description
Improper antibiotic use triggers outbreaks of hospital-acquired VRE infections. Relevant studies were gathered from Scopus, and PubMed. Over two decades, prevalence of VRE in humans and animals grew from 0.05 % to 99.0 % globally and from 1.0 % to 45.6 % in India. Identifying VRE at the species level helps identify acquired/intrinsic resistance. VRE infections, especially bloodstream infections, inflict significant mortality (60-70%-global; 23%-India) and economic burden ($539 million). Linezolid and daptomycin are frequently used without adequate clinical trial evidence. India lacks studies on prevalence, mortality and cost, which needs political will, public-private partnership, and prioritizing public health.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2213398424001593; http://dx.doi.org/10.1016/j.cegh.2024.101663; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85197468920&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S2213398424001593; https://impressions.manipal.edu/open-access-archive/10298; https://impressions.manipal.edu/cgi/viewcontent.cgi?article=11184&context=open-access-archive
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know